George Jagoe, MMV Executive Vice President, at MedTrop 2023

On September 10, MMV and PATH, co-leads of the Partnership for Vivax Elimination (PAVE) Consortium, co-hosted a panel with the Brazilian Ministry of Health at the Brazilian Society of Tropical Medicine Congress.

Watch George Jaogoe, Executive Vice-President for Access & Product Management at MMV, discuss the implementation of tafenoquine and the Standard G6PD test in the country's health system and what it means for other countries in the region.